自身免疫性肝炎大鼠血清IL-38和β2GPI水平及其与肝组织病变的关系*

doi:10.3969/j.issn.1672-5069.2021.06.009

实用肝脏病杂志 ›› 2021, Vol. 24 ›› Issue (6): 803-806.doi: 10.3969/j.issn.1672-5069.2021.06.009

自身免疫性肝炎大鼠血清IL-38和β2GPI水平及其与肝组织病变的关系^*

史雪丽, 张万里, 毛俊, 颜悦蓉

430000 武汉市优抚医院检验科(史雪丽,毛俊,张万里);湖北文理学院附属医院,襄阳市中心医院消化内科(颜悦蓉)

收稿日期:2021-01-29 出版日期:2021-11-10 发布日期:2021-11-15
通讯作者: 颜悦蓉,E-mail:yanyuerong@gmail.com
作者简介:史雪丽,女,37岁,大学本科,主管检验师,E-mail:sxl19840120@163.com
基金资助:
^*湖北省自然科学基金资助项目(编号:WJ2015CB075)

Serum IL-38 and β2GPI levels in rats with autoimmune hepatitis and their relationship with liver tissue lesions

Shi Xueli, Zhang Wanli, Mao Jun

Clinical Laboratory, Youfu Hospital, Wuhan 430000, Hubei Province, China

Received:2021-01-29 Online:2021-11-10 Published:2021-11-15

摘要/Abstract

摘要： 目的研究自身免疫性肝炎(AIH)大鼠血清白介素-38(IL-38)和β2糖蛋白I(β2GPI)水平及其与肝组织病变的关系。方法在40只大鼠,采用肝细胞特异性脂蛋白联合弗氏完全佐剂腹腔注射法建立AIH大鼠模型,取肝组织行病理学检查,采用ELISA法检测大鼠血清IL-38和β2GPI水平。结果 8只重度肝组织病变的AIH大鼠血清IL-38水平为(63.8±9.5)pg/ml,显著低于17只轻度或15只中度AIH大鼠【分别为(100.3±16.9)pg/ml和(85.1±11.3)pg/ml,P<0.05),而血清β2GPI水平为(4005.9±428.6)μg/L,显著高于轻度或中度AIH大鼠【分别为(2752.1±310.9)μg/L和(3190.5±362.7)μg/L,P<0.05】;6只3级肝组织血管病变的AIH大鼠血清IL-38水平为(39.5±6.9)pg/ml,显著低于18只1级或16只2级血管病变的AIH大鼠【分别为(102.1±17.2)pg/ml和(88.4±11.5)pg/ml,P<0.05】,而血清β2GPI水平为(3866.3±401.7)μg/L,显著高于1级或2级AIH大鼠【分别为(2779.3±309.0)μg/L和(3341.5±370.2)μg/L,P<0.05】。结论随着肝组织血管病变的加重,AIH大鼠血清IL-38水平随之降低,而β2GPI水平随之升高,这两种细胞因子的平衡可能参与了AIH的发病过程。

关键词: 自身免疫性肝炎, 白介素-38, β2糖蛋白抗体I, 肝组织病变, 大鼠

Abstract: Objective The aim of this study was to serum interleukin-38 (IL-38) and β2 glycoprotein I(β2GPI) levels in rats with autoimmune hepatitis (AIH) and their relationship with liver tissue lesions. Methods The AIH model was established by liver-specific lipoprotein and complete Freund' s adjuvant intraperitoneal injection. The liver tissues was obtained for phthological examination, and serum IL-38 and β2GPI levels were detected by ELISA. Results SerumIL-38 level in 8 AIH rats with severe hepatic injuries was (63.8±9.5)pg/ml, significantly lower than in 17 rats with mild or 15 rats with moderate hepatic injuries [(100.3±16.9)pg/ml and (85.1±11.3)pg/ml, respectively, P<0.05), while serum β2GPI level was (4005.9±428.6)μg/L, significantly higher than in rats with mild or moderate hepatic injuries [(2752.1±310.9)μg/L and (3190.5±362.7)μg/L, respectively, P<0.05]; serum IL-38 level in 6 rats with hepatic vascular lesion grade 3 was (39.5±6.9)pg/ml, significantly lower than in 18 rats with grade 1 or 16 rats with grade 2 hepatic vascular lesions [(102.1±17.2)pg/ml and (88.4±11.5)pg/ml, respectively, P<0.05], while serum β2GPI level was (3866.3±401.7)μg/L, much higher than in rats with grade 1 or 2 [(2779.3±309.0)μg/L and (3341.5±370.2)μg/L, respectively, P<0.05]. Conclusion Serum IL-38 levels decrease, while serum β2GPI levels increase with the deterioration of liver tissue injuries in rats with AIH, and the balance of the two cytokines might take part in the pathogenesis of AIH, which needs further investigation.

Key words: Autoimmune hepatitis, Interleukin-38, β2 glycoprotein I, Liver vascular lesions, Rats

史雪丽, 张万里, 毛俊, 颜悦蓉. 自身免疫性肝炎大鼠血清IL-38和β2GPI水平及其与肝组织病变的关系^*[J]. 实用肝脏病杂志, 2021, 24(6): 803-806.

Shi Xueli, Zhang Wanli, Mao Jun. Serum IL-38 and β2GPI levels in rats with autoimmune hepatitis and their relationship with liver tissue lesions[J]. Journal of Practical Hepatology, 2021, 24(6): 803-806.

参考文献

[1] Kerkar N, Chan A. Autoimmune hepatitis, sclerosing cholangitis, and autoimmune sclerosing cholangitis or overlap syndrome. Clin Liver Dis, 2018, 22(4):689-702.
[2] Sebode M, Hartl J, Vergani D, et al. Autoimmune hepatitis: From current knowledge and clinical practice to future research agenda. Liver Int, 2018, 38(1):15-22.
[3] HayatDavoudi G, Makvandi M, Teimoori A, et al. Frequency of OBI among patients with autoimmune hepatitis. Asian Pac J Cancer Prev, 2020, 21(9):2555-2559.
[4] van deVeerdonk FL, de Graaf DM, Joosten LA, et al. Biology of IL-38 and its role in disease. Immunol Rev, 2018, 281(1):191-196.
[5] Xu WD, Su LC, Liu XY, et al. IL-38: A novel cytokine in systemic lupus erythematosus pathogenesis. J Cell Mol Med, 2020, 24(21):12379-12389.
[6] Jing X,Tian Z, Gao P, et al. HBsAg/β2GPI activates the NF κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma. Oncol Rep, 2018, 40(2):1035-1045.
[7] Petri M. Improvements in diagnosis and risk assessment of primary and secondaryantiphospholipid syndrome. Hematology Am Soc Hematol Educ Program, 2019, 2019(1):415-420.
[8] Benagiano M, Borghi MO, Romagnoli J, et al. Interleukin-17/Interleukin-21 and Interferon-γ producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome. Haematologica, 2019, 104(12):2519-2527.
[9] Aljumah AA, Al Jarallah B, Albenmousa A, et al. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi J Gastroenterol, 2018, 24(l):1-20.
[10] 王莉,李家斌,马勇,等.脂多糖在慢性乙型肝炎肝内血管病变中的作用.实用肝脏病杂志,2012,15(1):14-17.
[11] Czaja AJ. Under-evaluated or unassessed pathogenic pathways in autoimmune hepatitis and implications for future management. Dig Dis Sci, 2018, 63(7):1706-1725.
[12] 彭小燕,徐莉娟,刘鹏,等.自身免疫性肝炎患者血清腺苷脱氨酶水平与肝组织炎症活动程度的关系及对治疗应答的影响.实用肝脏病杂志,2019,22(2):200-203.
[13] Wang QX, Yan L, Ma X. Autoimmunehepatitis in the Asia-Pacific area. J Clin Transl Hepatol, 2018, 6(1):48-56.
[14] Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity, 2013, 39(6):1003-1018.
[15] Mora J,Schlemmer A, Wittig I, et al. Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J Mol Cell Biol, 2016, 8(5):426-438.
[16] Xie L, Huang Z, Li H, et al. IL-38: A new player in inflammatory autoimmune disorders. Biomolecules, 2019, 9(8):345-367.
[17] Virachith S, Saito M, Watanabe Y, et al. Anti-β2 -glycoprotein I antibody with DNA binding activity enters living monocytes via cell surface DNA and induces tissue factor expression. Clin Exp Immunol, 2019, 195(2):167-178.
[18] Colasanti T, Alessandri C, Capozzi A, et al. Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. Blood, 2012, 120(16):3360-3370.
[19] Ruben E, Planer W,Chinnaraj M, et al. The J-elongated conformation of β2-glycoprotein I predominates in solution: implications for our understanding of antiphospholipid syndrome. J Biol Chem, 2020, 295(31):10794-10806.
[20] Liu YM, Zhang WY, Wang ZF,et al. High expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection. J Med Virol, 2014, 86(8):1296-1306.
[21] Wang H, Wang X, Zhang M, et al. Beta2-glycoprotein I in hepatitis B virus infection patients with hepatocellular carcinoma, chronic hepatitis B and acute hepatitis B. Int J Clin Exp Med, 2016, 9(10):10846-10852.

自身免疫性肝炎大鼠血清IL-38和β2GPI水平及其与肝组织病变的关系^*

Serum IL-38 and β2GPI levels in rats with autoimmune hepatitis and their relationship with liver tissue lesions

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	顾雪香, 李祥玉, 单勤星. 柴胡皂苷a通过影响PPARα信号通路对非酒精性脂肪性肝病大鼠肝脂肪变的保护作用^*[J]. 实用肝脏病杂志, 2021, 24(6): 807-810.
[2]	肖金玉, 王延峰, 文小霞. 自身免疫性肝炎患者血清趋化因子CCL4和CXCL10水平及其临床意义探讨[J]. 实用肝脏病杂志, 2021, 24(6): 827-830.
[3]	王绮夏, 马雄. 自身免疫性肝病精准诊治与临床转化研究的思考^*[J]. 实用肝脏病杂志, 2021, 24(4): 457-459.
[4]	李变利, 徐丽红. 药物性肝损伤、药物诱导性自身免疫性肝炎和自身免疫性肝炎鉴别诊断研究进展^*[J]. 实用肝脏病杂志, 2021, 24(4): 460-463.
[5]	梁玉萍, 粟全球, 张慧, 王佳林. 自身免疫性肝炎患者维生素D缺乏调查及其临床特征分析^*[J]. 实用肝脏病杂志, 2021, 24(4): 464-467.
[6]	刘娜, 张华敏, 邓巧娟. 抑制TRAF6基因表达对自身免疫性肝炎大鼠肝组织NF-κB信号通路相关蛋白表达的影响[J]. 实用肝脏病杂志, 2021, 24(4): 468-471.
[7]	齐玫, 张瑞金, 田树萍, 于艳华. 平均血小板体积对自身免疫性肝炎患者治疗不应答的预测价值分析[J]. 实用肝脏病杂志, 2021, 24(3): 371-374.
[8]	荣海芳, 王立国. 胆总管结扎诱导大鼠肝肺综合征模型的建立初步研究[J]. 实用肝脏病杂志, 2021, 24(2): 176-179.
[9]	苏琪皓, 任丽梅, 姜凤霞, 武金宝, 江振宇. 蒙药额力根II号对肝纤维化大鼠的保护作用研究[J]. 实用肝脏病杂志, 2021, 24(2): 180-183.
[10]	聂柳, 彭罕鸣, 廖东亮. 泼尼松和硫唑嘌呤联合熊去氧胆酸治疗自身免疫性肝炎患者疗效研究[J]. 实用肝脏病杂志, 2021, 24(2): 224-227.
[11]	荣爱梅, 张超, 吴慧丽. 西罗莫司对高脂饮食诱导的NAFLD大鼠外周血Treg/Th17细胞的影响[J]. 实用肝脏病杂志, 2021, 24(1): 10-13.
[12]	李庆玲, 何树光, 易小明, 段婷娜, 周意. 雷公藤多甙联合异甘草酸镁治疗自身免疫性肝炎患者外周血淋巴细胞PD-1和PD-L1变化[J]. 实用肝脏病杂志, 2021, 24(1): 79-82.
[13]	李伟, 郭春霞, 刘苏南. 白藜芦醇对部分肝切除术大鼠肝再生和肝组织NK细胞活性的影响^*[J]. 实用肝脏病杂志, 2020, 23(6): 785-788.
[14]	王雨, 王楠, 王巧侠, 马清华, 潘新杰, 付建军. 利肝隆联合异甘草酸镁治疗自身免疫性肝炎患者疗效及其对血清趋化因子水平的影响^*[J]. 实用肝脏病杂志, 2020, 23(6): 821-824.
[15]	凌晶, 张友健, 宋雄峰. 自身免疫性肝炎患者血清趋化因子和GP73水平变化及其临床意义研究[J]. 实用肝脏病杂志, 2020, 23(6): 825-828.